ImmuneOnco Biopharmaceuticals Files for HKSE IPO with Comprehensive Tumor Immunotherapy Pipeline
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd has submitted an initial public offering (IPO) filing to the...
Deals
Antengene and BeiGene Collaborate on Selinexor and Tislelizumab Combination Trial for Lymphoma
China-based Antengene Corporation Ltd (HKG: 6996) has announced a clinical trial collaboration with BeiGene Inc....
Sanyou Biopharmaceuticals and Dragon Sail Form Strategic Partnership for Global Biopharma Services
China-based Sanyou Biopharmaceuticals Co., Ltd has entered into a long-term strategic partnership with compatriot firm...
Westlake Therapeutics Secures RMB 100 Million in Series A+ Funding for Red Cell Therapy Pipeline
Hangzhou-based cell therapy firm Westlake Therapeutics, founded in 2019, has successfully raised over RMB 100...
PhenoVision Bio Secures Angel Funding for Spatial Multi-Omics Technology Platform
Beijing-based PhenoVision Biotech, a one-stop spatial multi-omics solution provider, has reportedly secured “tens of millions”...
Genor Biopharma and Abogen Biosciences Collaborate on Cancer mRNA Therapies
China’s Genor Biopharma Co., Ltd (HKG: 6998) has entered into a co-development agreement with compatriot...
Sunshine Guojian Pharmaceutical Signs Licensing Deal for Cipterbin ADC Development
China-based Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a subsidiary of 3SBio Inc. (HKG: 1530), has...
Guangzhou Baiyunshan Halts Spinning-off of Guangzhou Pharmaceutical Amid HK Capital Shifts
China-based Guangzhou Baiyunshan Pharmaceutical Co., Ltd (SHA: 600332) has announced the suspension of the spinning-off...
Helixon Secures RMB 500 Million in Series A Round to Advance AI-Driven Drug Development
Beijing-based Helixon, an artificial intelligence (AI)-empowered pharmaceutical company, has reportedly secured RMB 500 million (USD...
Suzhou Teligene Ltd Plans IPO on Shanghai STAR Market for Cancer Drug Development
China-based Suzhou Teligene Ltd has announced plans for an initial public offering (IPO) of 63.52...
Nanjing CRO Caremo Secures RMB 150 Million in Series A Round
Nanjing-based Contract Research Organization (CRO) Caremo has reportedly secured RMB 150 million (USD 22.3 million)...
Winsan Medical Acquires 52% Stake in Goodfeel Dental Clinic for RMB 156 Million
China-based Winsan (Chengdu) Medical Science and Technology Co., Ltd (SHA: 600767) is set to acquire...
China NT Pharma Group Inks Licensing Deal for Orticumab in Asia
China-based China NT Pharma Group Company Ltd (HKG: 1011) has announced a licensing agreement with...
Mega Genomics Limited Makes Hong Kong IPO Debut at HKD 18 Per Share
China-based gene testing platform company Mega Genomics Limited has successfully completed an initial public offering...
Eureka Biotechnology Secures RMB 100 Million for Cell and Gene Therapy Solutions
Shenzhen-based Eureka Biotechnology, a company specializing in comprehensive solutions for the cell and gene therapy...
Therorna Secures Over RMB 280 Million in Series A Round to Accelerate circRNA Tech Development
China-based Therorna Inc., a biotech company specializing in cutting-edge circular RNA (circRNA) technology for next-generation...
Shanghai ShineYo Medical Device Secures RMB 100 Million in Series A Round
Shanghai ShineYo Medical Device Co., Ltd, a company specializing in electrophysiology and peripheral intervention, has...
Boehringer Ingelheim Venture Fund and Hong Kong Science Park Launch Co-Incubation Plan
Germany-based pharmaceutical giant Boehringer Ingelheim’s venture fund (BIVF) and China-based Hong Kong Science & Technology...
Shenzhen AXBio Closes USD 100 Million Series B Round for Sequencing Tech Expansion
Shenzhen-based fourth-generation sequencing company Anxuyuan Biotechnology (shenzhen) Company Limited (AXBio) has reportedly secured close to...
Iomics Biosciences Secures RMB 100 Million for Proteomics and Spatialomics Expansion
Beijing-based Iomics Biosciences Co., Ltd, a developer of gene sequencing and diagnostic equipment, has reportedly...